Wound Care Specialist
A board-certified podiatrist, Lawrence A. Lavery, D.P.M., M.P.H., is an internationally recognized expert in diabetic foot complications, including diabetic foot ulcers, soft tissue and bone infections, Charcot arthropathy, and prevention strategies. As a leading member of the team that established UT Southwestern’s Wound Care Clinic, he’s been at the forefront of expanding options for patients in North Texas.
Dr. Lavery currently is a member of the International Working Group on the Diabetic Foot, including both the diabetic foot infection and diabetic foot prevention study groups. He is past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section.
"We apply comprehensive solutions focused on helping patients recover. For some patients, this means salvaging a limb using advanced techniques based on the newest research available in wound care.”
By combining groundbreaking research with scientific treatment options, he’s able to offer novel, evidenced-based treatments. His expertise includes the full range of wound care options – including stem cell-based wound therapy, bioengineered tissue, electrical stimulation, and negative pressure wound therapy.
“One of the most important advantages I can offer patients is access to a full spectrum of therapies based on scientific evidence, and a comprehensive team of clinicians and surgeons that are dedicated to Diabetic Limb Salvage. We have a close working relationship with world-class vascular surgeons, infectious disease experts, orthopedic surgeons, and therapists. Our system fosters communication and collaboration,” Dr. Lavery says.
“We use the proven treatments that might be considered old school, as well as many of the most innovative treatments in the world. And because we collaborate with industry to study new technologies, we often have new treatments that are not available at other centers,” he adds.
Dr. Lavery says great progress has been accomplished with science-based strategies to save limbs. However, he stresses patients should seek care sooner rather than later because early treatment can be key to improving their chances of recovery and preventing an amputation.
We have a strong commitment to research and investigating new therapies. Dr. Lavery leads a research team that’s focused on improving treatment and prevention of diabetic foot complications. Dr. Lavery’s groundbreaking work has received research funding from the National Institute of Health (NIH), Veterans Administration (VA), American Diabetes Association, Agency for Health Quality Research, Qatar National Research Foundation, American College of Foot and Ankle Surgeons, American Podiatric Medical Association, and private industry. This includes studies funded by the National Institutes of Health (NIH), such as identifying biomarkers in diabetic patients to diagnose and monitor foot infections and to help doctors understand why some people heal and some do not.